Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2014 by University of Virginia.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Kambiz Kalantarinia, University of Virginia
ClinicalTrials.gov Identifier:
NCT01101269
First received: April 6, 2010
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)